Currax Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsCurrax Pharmaceuticals

Currax Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Onzetra	Sumatriptan	2016-01-27	2024-2036	Migraine disorders , Cluster headache , Juvenile arthritis , Ankylosing spondylitis , Rheumatoid arthritis , Headache , Fever , Inflammation , Osteoarthritis , Bursitis , Back pain , Common cold , Toothache , Dysmenorrhea , Gout
Silenor	Doxepin	2010-03-17	2027-2030	Atopic dermatitis , Pruritus , Pain , Anxiety disorders , Psychotic affective disorders , Depressive disorder
Treximet	Naproxen, Sumatriptan	2008-04-15	2025-2026	Juvenile arthritis , Ankylosing spondylitis , Rheumatoid arthritis , Headache , Fever , Inflammation , Osteoarthritis , Bursitis , Back pain , Common cold , Toothache , Dysmenorrhea , Gout , Gastroesophageal reflux , Helicobacter infections , Duodenal ulcer , Zollinger-ellison syndrome , Esophagitis , Heartburn , Nausea , Sleep initiation and maintenance disorders , Allergic rhinitis perennial , Urticaria , Motion sickness , Sneezing , Anxiety disorders , Sinusitis , Asthma , Stomach ulcer , Migraine disorders , Cluster headache , Whooping cough , Bronchitis , Cough , Pharyngitis , Laryngitis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

therapeutic equivalency

,

healthy volunteers/patients

parkinson disease

,

breast neoplasms

,

,

radiodermatitis

,

,

,

non-small-cell lung carcinoma

,

thyroid neoplasms

,

esophageal neoplasms

,

,

,

,

second primary neoplasms

,

small cell lung carcinoma

,

,

,

thymus neoplasms

,

laryngeal neoplasms

,

hypopharyngeal neoplasms

,

irritable bowel syndrome

,

,

,

psychophysiologic disorders

,

somatoform disorders

,

,

,

,

anxiety disorders

,

head and neck neoplasms

,

,

,

,

sleep initiation and maintenance disorders

,

,

,

treatment-resistant depressive disorder

,

major depressive disorder

,

depressive disorder

,

,

,

healthy volunteers/patients

,

drug-related side effects and adverse reactions

,

drug interactions

,

bipolar disorder

,

gastrointestinal diseases

,

,

digestive system diseases

,

nasopharyngeal carcinoma

healthy volunteers/patients

,

long qt syndrome

,

knee osteoarthritis

,

,

stomach neoplasms

,

,

chronic obstructive pulmonary disease

,

atrial fibrillation

,

obstructive lung diseases

,

exocrine pancreatic insufficiency

,

left ventricular function

,

,

non-hodgkin lymphoma

,

multiple myeloma

,

atopic dermatitis

,

,

,

clear cell adenocarcinoma

,

adenomyoepithelioma

,

,

non-small-cell lung carcinoma

,

,

,

chronic renal insufficiency

,

kidney diseases

,

,

myeloid leukemia acute

,

myeloid leukemia

,

renal cell carcinoma

,

hypertriglyceridemia

,

chronic kidney failure

,

,

neoplasm metastasis

,

,

urologic neoplasms

,

kidney neoplasms

,

neoplasms by site

,

,

,

psychotic disorders

,

,

,

type 2 diabetes mellitus

,

,

,

bipolar disorder

,

diabetes mellitus

,

coronary artery disease

Histone-arginine methyltransferase carm1

,

squamous cell carcinoma of head and neck

,

,

head and neck neoplasms

,

squamous cell carcinoma

,

squamous cell neoplasms

,

maxillary sinus neoplasms

,

paranasal sinus neoplasms

parkinson disease

,

breast neoplasms

,

,

radiodermatitis

,

,

,

non-small-cell lung carcinoma

,

thyroid neoplasms

,

esophageal neoplasms

,

,

,

,

second primary neoplasms

,

small cell lung carcinoma

,

,

,

thymus neoplasms

,

laryngeal neoplasms

,

hypopharyngeal neoplasms

,

irritable bowel syndrome

,

,

,

psychophysiologic disorders

,

somatoform disorders

,

,

,

,

anxiety disorders

,

head and neck neoplasms

,

,

,

,

sleep initiation and maintenance disorders

,

,

,

treatment-resistant depressive disorder

,

major depressive disorder

,

depressive disorder

,

,

,

healthy volunteers/patients

,

drug-related side effects and adverse reactions

,

drug interactions

,

bipolar disorder

,

gastrointestinal diseases

,

,

digestive system diseases

,

nasopharyngeal carcinoma

Lorcaserin hydrochloride anhydrous

healthy volunteers/patients

,

coronary artery disease

,

esophageal neoplasms

,

,

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

chronic urticaria

,

,

type 1 diabetes mellitus

,

triple negative breast neoplasms

,

ovarian epithelial carcinoma

,

gastrointestinal endoscopy

,

,

renal cell carcinoma

,

cholangiocarcinoma

,

,

endometrial neoplasms

,

,

,

,

acute kidney injury

,

non-small-cell lung carcinoma

,

breast neoplasms

,

,

prostatic neoplasms

,

ovarian neoplasms

,

small cell lung carcinoma

,

,

neoplasm metastasis

,

stomach neoplasms

,

urinary bladder neoplasms

,

human influenza

,

,

esophageal squamous cell carcinoma

,

hepatocellular carcinoma

,

liver neoplasms

,

hypertriglyceridemia

,

gastroesophageal reflux

,

,

respiratory distress syndrome

,

respiratory tract infections

,

,

coronavirus infections

,

respiratory insufficiency

,

severe acute respiratory syndrome

,

,

exercise-induced asthma

,

bronchial spasm

,

exercise-induced allergies

,

disease progression

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

chronic obstructive pulmonary disease

,

obstructive lung diseases

,

renal insufficiency

,

kidney function tests

,

,

thromboembolism

,

atherosclerosis

,

systemic lupus erythematosus

,

post-traumatic stress disorders

,

combat disorders

Lorcaserin hydrochloride hemihydrate

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use